Blog

  • Brazil’s Eletrobras changes name to Axia Energia

    Brazil’s Eletrobras changes name to Axia Energia

    SAO PAULO, Oct 22 (Reuters) – Brazilian power company Eletrobras announced on Wednesday it is changing its name to Axia Energia, in a development it said will not impact any contractual, business, or regulatory commitments established by the firm.

    In a securities filing, Eletrobras also said its Sao Paulo-listed ordinary shares’ ticker “ELET3” will change to “AXIA3” starting on November 10, adding the new identity will be gradually incorporated into all its communications and assets.

    Sign up here.

    The new name removes reference to Brazil, a legacy of the state’s ownership of the company. Eletrobras’ privatization process was completed in mid-2022, although the Brazilian government continues to have almost 30% of its total shares.

    In recent years, Eletrobras has reinforced measures to disassociate itself from issues linked to the state. For example, the firm last week sold its stake in the state-run nuclear energy company Eletronuclear.

    The company is responsible for 17% of the country’s power generation capacity and 37% of the total transmission lines in the national interconnected system. Its installed capacity has 81 plants, 47 of which are hydroelectric, 33 wind and one solar.

    The Brazilian government pledged this year to no longer question its 10% voting limit in the company, imposed on any shareholder or group of shareholders, in exchange for more representation on the firm’s board.

    President Luiz Inacio Lula da Silva has always opposed the way the company was privatized during former President Jair Bolsonaro’s term.

    Reporting by Isabel Teles, Alberto Alerigi Jr. and Roberto Samora; Writing by Fernando Cardoso; Editing by Brendan O’Boyle and Diane Craft

    Our Standards: The Thomson Reuters Trust Principles., opens new tab

    Continue Reading

  • Citi board names Jane Fraser as chair and awards her $25mn bonus

    Citi board names Jane Fraser as chair and awards her $25mn bonus

    Unlock the Editor’s Digest for free

    Citigroup has elected chief executive Jane Fraser as chair of the US bank’s board of directors and is paying her a one-off $25mn bonus, underscoring her leadership position atop the lender as it pursues a radical overhaul.

    When Fraser became chief executive in 2021, Citi split the CEO and chair roles, with John Dugan acting as chair.

    “Citi is in a fundamentally different place than it was when these roles were separated,” Dugan, who will now be Citi’s lead independent director, said in a statement. “Jane’s very deliberate plan to make Citi a simpler and more focused bank has created meaningful shareholder value.”

    This is a developing story

    Continue Reading

  • Get More Women to Cardiac Rehab, AHA Asserts

    Get More Women to Cardiac Rehab, AHA Asserts

    More focus is needed on female-specific barriers to enrollment and completion of programs that can improve their outcomes.

    Despite evidence to support the role that cardiac rehabilitation can play in improving outcomes after serious…

    Continue Reading

  • Just a moment…

    Just a moment…

    Continue Reading

  • IHC suspends single bench’s LG poll verdict

    IHC suspends single bench’s LG poll verdict

    .


    ISLAMABAD:

    The Islamabad High Court (IHC) suspended on Wednesday a…

    Continue Reading

  • QuantumScape Announces Shipment of B1 Samples, Achieving a Key Annual Goal

    SAN JOSE, Calif. — October 22, 2025 — QuantumScape Corporation (NYSE: QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced that it has begun shipping B1 samples of its QSE-5 cell. The company reached this milestone during the third quarter of 2025, achieving one of the company’s key goals for the year.

    These samples are the most advanced QS cells to date and feature separators produced using the company’s groundbreaking Cobra process. By combining the high-performance QSE-5 design with more efficient production processes, these cells represent a major step toward high-volume commercial production of QS technology for electric vehicles and other applications.

    Cobra-based QSE-5 cells are featured in QS’s first vehicle program with the VW Group, the Ducati V21L motorcycle. The Ducati program is designed as a real-world demonstration of the no-compromise performance profile of QS solid-state battery technology.

    This cell shipment milestone reflects QS’s commitment to executing on its roadmap and advancing next-generation battery technology. In a further step toward bringing QS technology to scale and achieving automotive-grade reliability, the company is installing a highly automated cell production pilot line, the Eagle Line, at its headquarters in San Jose, California.

    “We are proud to announce the start of deliveries of these QSE-5 samples,” said Dr. Luca Fasoli, Chief Operating Officer of QS. “We are working together with our partners to bring our groundbreaking solid-state lithium-metal battery technology to market as quickly as possible. This announcement is another critical step toward achieving our goal of revolutionizing energy storage.”

    ###

    About QuantumScape Corporation

    QuantumScape is on a mission to revolutionize energy storage to enable a sustainable future. The company’s next-generation solid-state lithium-metal battery technology is designed to enable greater energy density, faster charging and enhanced safety to support the transition away from legacy energy sources toward a lower carbon future. For more information, visit www.quantumscape.com.

    Forward-Looking Statements 

    Certain information in this press release may be considered “forward-looking statements,” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, statements regarding the development, commercialization, and high-volume scale-up of QS’s battery technology, the anticipated benefits from successful installation and operation of production equipment for the Eagle Line, including battery cell reliability and increased production automation, the performance of QS’s technology and its applications, the achievement of technical milestones and goals, and the potential impacts of QS’s technology for electric vehicles and other applications, among others. These forward-looking statements are based on management’s current expectations, assumptions, hopes, beliefs, intentions and strategies regarding future events and are based on currently available information as to the outcome and timing of future events. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements due to various risks, including the successful development and commercialization of our solid-state battery technology, achieving technical and financial milestones, building out of high-volume processes and otherwise scaling production, achieving the performance, quality, consistency, reliability, safety, cost and throughput required for commercial production and sale, changes in economic and financial conditions, market demand for EVs, retaining key personnel, competition, regulatory changes, broader economic conditions, and other factors, including those discussed in the section titled “Risk Factors” in our Annual Report and Quarterly Reports and other documents filed with the Securities and Exchange Commission from time to time. Except as otherwise required by applicable law, the company disclaims any duty to update any forward-looking statements.

    Continue Reading

  • Moderna halts development of birth defect vaccine after trial setback – Reuters

    1. Moderna halts development of birth defect vaccine after trial setback  Reuters
    2. Moderna says key study of its CMV vaccine, expected to be its next big win, failed  statnews.com
    3. Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint  Yahoo Finance
    4. Moderna Drops Vaccine for Birth Defects After Trial Failure  Barron’s
    5. Moderna Vaccine Fails to Prevent Infection Tied to Birth Defects  Bloomberg.com

    Continue Reading

  • NASA Finds Signs of Ancient Microbial Life in a Rock on Mars

    NASA Finds Signs of Ancient Microbial Life in a Rock on Mars

    Did Mars once harbor life? 

    NASA’s Perseverance rover’s latest discovery of potential biosignatures from a rock formation named Cheyava Falls might have just answered that question, hinting that some form of life could have been hidden…

    Continue Reading

  • Resonant Memory: Works by Steina and Woody Vašulka – Events

    Resonant Memory: Works by Steina and Woody Vašulka – Events

    Robyn Farrell is Senior Curator and Director of Curatorial Affairs at The Kitchen in New York where she oversees the exhibition, performance, and publication program. Her research interests include conceptual art and the moving image, emerging…

    Continue Reading

  • Madison Beer announces ‘Locket’ – The Music Universe

    Madison Beer announces ‘Locket’ – The Music Universe

    The album will be available on January 16th

    Platinum-selling multi-hyphenate creative force Madison Beer announces her next studio album, Locket, out via Epic Records on January 16th. Written and co-produced by Beer, the album also features…

    Continue Reading